Thermal plasma technology: Where do we stand and where are we going?

被引：296
|
作者：
Pfender, E
机构：
[1] Univ Minnesota, Dept Mech Engn, Minneapolis, MN 55455 USA
[2] Univ Minnesota, ERC Plasma Aided Mfg, Minneapolis, MN 55455 USA
来源：
PLASMA CHEMISTRY AND PLASMA PROCESSING | 1999年 / 19卷 / 01期
基金：
美国国家科学基金会;
关键词：
thermal plasma technology assessment; research and development; overview;
D O I：
10.1023/A:1021899731587
中图分类号：
TQ [化学工业];
学科分类号：
0817 ;
摘要：
In this overview, an attempt is made to assess the present and future research and development in thermal plasma processing of materials restricted to (1) thermal plasma coating technologies, (2) thermal plasma synthesis of fine powders, (3) thermal plasma waste destruction, and (4) thermal plasma spheroidization and densification. Since thermal plasma processing is, in general, governed by a large number of parameters, implementation of controls becomes mandatory. The lack of sufficient controls combined with economic drawbacks in some cases has been the main obstacle for the growth of thermal plasma technology. Present R&D efforts, however address these problems.
引用
收藏
页码：1 / 31
页数：31
相关论文
共 50 条
  • [1] Thermal Plasma Technology: Where Do We Stand and Where Are We Going?
    E. Pfender
    Plasma Chemistry and Plasma Processing, 1999, 19 : 1 - 31
  • [2] Homocysteine research - where do we stand and where are we going?
    Herrmann, W
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2005, 43 (10) : 977 - 979
  • [3] Addictive behaviors: where do we stand, and where are we going?
    Thibaut, Florence
    Hoehe, Margret
    DIALOGUES IN CLINICAL NEUROSCIENCE, 2017, 19 (03) : 215 - 215
  • [4] ENDOCRINE THERAPY - WHERE DO WE STAND AND WHERE ARE WE GOING
    SCHRODER, FH
    CANCER SURVEYS, 1991, 11 : 177 - 194
  • [5] Aging Research-Where Do We Stand and Where Are We Going?
    Guarente, Leonard
    CELL, 2014, 159 (01) : 15 - 19
  • [6] Percutaneous Valve Replacement: Where do we stand? Where are we going?
    Roach, Emir Charles
    Gezgen, Gamze
    Gezgen, Baki
    HEALTHMED, 2010, 4 (04): : 955 - 963
  • [7] Cold Agglutinin Disease: Where Do We Stand, and Where Are We Going?
    Berentsen, Sigbjorn
    Malecka, Agnieszka
    Randen, Ulla
    Tjonnfjord, Geir E.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2020, 18 (01) : 35 - 44
  • [8] Pediatric liver transplantation: where do we stand? Where we are going to?
    Devictor, Denis
    Tissieres, Pierre
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2013, 7 (07) : 629 - 641
  • [9] Endoluminal Bariatric Interventions : Where do we stand ? Where are we going ?
    Unlu, Ozan
    Okoh, Alexis
    Yilmaz, Bulent
    Roach, Emir C.
    Olayan, May
    Shatnawei, Abdullah
    ACTA GASTRO-ENTEROLOGICA BELGICA, 2015, 78 (04) : 415 - 423
  • [10] Phage Therapy in the Resistance Era: Where Do We Stand and Where Are We Going?
    Luong, Tiffany
    Salabarria, Ann-Charlott
    Roach, Dwayne R.
    CLINICAL THERAPEUTICS, 2020, 42 (09) : 1659 - 1680
12345